✦ LIBER ✦

Prevalence of pulmonary arterial hypertension in scleroderma—Results from the Australian Scleroderma Interest Group

✍ Scribed by R. Padang; J. Byron; W. Stevens; P. Youssef; F. Kermeen; J. Zochling; K. Tymms; E. Gabbay; A. Sturgess; C. Hill; S. Proudman; D.S. Celermajer

Book ID: 119256816
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 66 KB
Volume: 18
Category: Article
ISSN: 1443-9506
DOI: 10.1016/j.hlc.2009.05.692

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of pulmonary arterial hyperte

Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis

✍ S. Phung; G. Strange; L. P. Chung; J. Leong; B. Dalton; J. Roddy; J. Deague; D. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Long-Term Outcome of Bosentan Treatment

Long-Term Outcome of Bosentan Treatment in Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated with the Scleroderma Spectrum of Diseases

✍ Reda E. Girgis; Stephen C. Mathai; Jerry A. Krishnan; Fredrick M. Wigley; Paul M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Importance of Hydration and Exercise in

Importance of Hydration and Exercise in the Diagnosis of Pulmonary Arterial Hypertension Secondary to Scleroderma

✍ Andrew T. Burns; Andre La Gerche; Wendy Stevens; Andrew I. MacIsaac; David L. Pr 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Long term outcome of bosentan treatment

Long term outcome of bosentan treatment in primary pulmonary hypertension (PPH) and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases (PAH-SSD)

✍ R.E Girgis; S.C Mathai; J.A Krishnan; F.M Wigley; P.M Hassoun 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Impact of oral cyclophosphamide on healt

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study

✍ Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC

Associations with digital ulcers in a la

Associations with digital ulcers in a large cohort of systemic sclerosis: Results from the Canadian Scleroderma Research Group registry

✍ Sarit Khimdas; Sarah Harding; Ash Bonner; Brittany Zummer; Murray Baron; Janet P 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 101 KB 👁 2 views